Valuation: DRI Healthcare Trust

Market Cap 740M 672M 621M 560M 1.06B 69.17B 1.1B 7.48B 2.96B 37.33B 2.78B 2.72B 118B P/E 2026 *
14.9x
P/E 2027 * 39.8x
Enterprise Value 1.28B 1.16B 1.07B 966M 1.82B 119B 1.89B 12.9B 5.1B 64.35B 4.79B 4.69B 203B EV / Sales 2026 *
6.5x
EV / Sales 2027 * 5.19x
Free-Float
99.76%
Yield 2026 *
3.18%
Yield 2027 * 3.32%
1 day-0.41%
1 week-1.13%
Current month+6.23%
1 month+7.77%
3 months+6.46%
6 months+19.39%
Current year+19.91%
1 week 18.92
Extreme 18.92
19.58
1 month 17.91
Extreme 17.91
19.84
Current year 15
Extreme 15
19.84
1 year 15
Extreme 15
19.84
3 years 10.39
Extreme 10.39
19.84
5 years 5.83
Extreme 5.83
19.84
10 years 5.83
Extreme 5.83
19.84
Manager TitleAgeSince
Chief Executive Officer 51 2020-05-31
Director of Finance/CFO - 2025-09-30
Chief Tech/Sci/R&D Officer - 2014-08-31
Director TitleAgeSince
Chairman 63 2021-01-21
Director/Board Member 51 2020-05-31
Director/Board Member 66 2021-01-21
Date Insider Type Main position Quantity % Market Cap. Importance
11/1/26 Option

Chairman

-3,033 0.0055%
11/1/26 Option

Chairman

1,409 0.0026%
10/30/26 TaxCompany -8,100 0.0147%
Change 5-day change 1-year change 3-year change Capi.($)
-0.41%-1.13%+20.89%+61.93% 742M
-1.13%-1.17%+38.55%+139.23% 1,275B
-1.36%-0.74%+39.64%+86.06% 680B
-0.59%-0.36%+25.14%+111.73% 521B
-0.76%+1.10%+41.43%+70.96% 389B
-0.75%-3.16%+54.39%+40.90% 356B
-1.83%-0.89%+26.00%+58.48% 305B
-1.65%-0.59%+1.55%+34.52% 287B
-0.95%-1.57%+34.01%+72.55% 250B
+1.60%-0.36%+37.21%+125.66% 208B
Average -0.78%-0.44%+31.88%+80.20% 427B
Weighted average by Cap. -0.98%-0.55%+34.95%+95.62%

Financials

2026 *2027 *
Net sales 196M 178M 165M 149M 281M 18.35B 291M 1.98B 785M 9.9B 737M 721M 31.29B 223M 202M 187M 168M 318M 20.8B 330M 2.25B 890M 11.22B 835M 818M 35.46B
Net income 50.09M 45.47M 42M 37.89M 71.54M 4.68B 74.28M 506M 200M 2.53B 188M 184M 7.98B 21.48M 19.5M 18.01M 16.25M 30.67M 2.01B 31.85M 217M 85.83M 1.08B 80.58M 78.88M 3.42B
Net Debt 536M 487M 449M 406M 766M 50.08B 795M 5.42B 2.14B 27.02B 2.01B 1.97B 85.38B 415M 376M 348M 314M 592M 38.73B 615M 4.19B 1.66B 20.9B 1.56B 1.52B 66.03B
Projected Income Statement - Annual - DRI Healthcare Trust
Logo DRI Healthcare Trust
DRI Healthcare Trust is a global pharmaceutical royalty monetization company. The Company's portfolio consists of 29 royalty streams on 23 products that treat conditions in a number of therapeutic areas, including oncology, neurology, ophthalmology, endocrinology, hematology, dermatology, as well as lysosomal storage disorders (LSD) and immunology. Its Royalty Assets include Ekterly, Eylea I, Eylea II, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Spinraza, Vonjo I, Vonjo II, Xolair, Zejula, Zytiga, and others. The Ekterly is an oral on-demand therapy for treating attacks associated with Hereditary Angioedema (HAE). The Eylea I is a vascular endothelial growth factor inhibitor initially indicated for the treatment of neovascular wet age-related macular degeneration. Natpara is indicated as an adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism.
Employees
32
Date Price Change Volume
26-11-17 $19.27 -0.41% 59,957
26-11-16 $19.35 +1.26% 52,867
26-11-13 $19.11 -1.85% 23,807
26-11-12 $19.47 -0.26% 35,984
26-11-11 $19.52 +0.15% 22,460
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - DRI Healthcare Trust
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
13.49USD
Average target price
17.49USD
Spread / Average Target
+29.62%
  1. Stock Market
  2. Stocks
  3. DHT.U Stock